Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

936.35

-6.20 (-0.66%)

< Home < Back

Zydus Lifesciences informs about press release

Date: 06-06-2022

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 6, 2022 titled ‘Zydus Lifesciences receives final approval from USFDA for Famotidine Tablets’.

The above information is a part of company’s filings submitted to BSE.